Penumbra SG&A Expenses 2014-2024 | PEN

Penumbra annual/quarterly sg&a expenses history and growth rate from 2014 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Penumbra sg&a expenses for the quarter ending September 30, 2024 were $0.140B, a 10.97% increase year-over-year.
  • Penumbra sg&a expenses for the twelve months ending September 30, 2024 were $0.556B, a 13.01% increase year-over-year.
  • Penumbra annual sg&a expenses for 2023 were $0.506B, a 12.62% increase from 2022.
  • Penumbra annual sg&a expenses for 2022 were $0.45B, a 18.87% increase from 2021.
  • Penumbra annual sg&a expenses for 2021 were $0.378B, a 31.79% increase from 2020.
Penumbra Annual SG&A Expenses
(Millions of US $)
2023 $506
2022 $450
2021 $378
2020 $287
2019 $273
2018 $226
2017 $184
2016 $148
2015 $102
2014 $64
2013 $45
Penumbra Quarterly SG&A Expenses
(Millions of US $)
2024-09-30 $140
2024-06-30 $142
2024-03-31 $144
2023-12-31 $130
2023-09-30 $126
2023-06-30 $127
2023-03-31 $123
2022-12-31 $116
2022-09-30 $109
2022-06-30 $115
2022-03-31 $111
2021-12-31 $114
2021-09-30 $94
2021-06-30 $91
2021-03-31 $80
2020-12-31 $77
2020-09-30 $76
2020-06-30 $60
2020-03-31 $74
2019-12-31 $75
2019-09-30 $69
2019-06-30 $68
2019-03-31 $61
2018-12-31 $61
2018-09-30 $56
2018-06-30 $55
2018-03-31 $54
2017-12-31 $51
2017-09-30 $46
2017-06-30 $44
2017-03-31 $43
2016-12-31 $42
2016-09-30 $38
2016-06-30 $36
2016-03-31 $33
2015-12-31 $29
2015-09-30 $27
2015-06-30 $26
2015-03-31 $20
2014-12-31
2014-09-30 $17
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.075B $1.059B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $211.041B 25.75
Intuitive Surgical (ISRG) United States $191.072B 99.90
Alcon (ALC) Switzerland $45.679B 32.16
IQVIA Holdings (IQV) United States $39.790B 21.92
Edwards Lifesciences (EW) United States $39.062B 24.81
IDEXX Laboratories (IDXX) United States $35.479B 41.78
DexCom (DXCM) United States $27.326B 41.15
Waters (WAT) United States $22.831B 33.76
SONOVA HOLDING (SONVY) Switzerland $22.110B 0.00
STERIS (STE) Ireland $21.616B 24.91
Hologic (HOLX) United States $18.294B 19.30
Sysmex ADR (SSMXY) Japan $12.864B 40.34
Fresenius Medical Care AG KGaA (FMS) Germany $12.499B 12.83
Globus Medical (GMED) United States $10.952B 27.89
Teleflex (TFX) United States $9.082B 14.49
Masimo (MASI) United States $8.696B 42.08
Glaukos (GKOS) United States $7.816B 0.00
PROCEPT BioRobotics (PRCT) United States $5.170B 0.00
Integer Holdings (ITGR) United States $4.587B 26.00
Inari Medical (NARI) United States $3.009B 0.00
TransMedics (TMDX) United States $2.886B 91.47
LivaNova (LIVN) United Kingdom $2.804B 16.18
Veracyte (VCYT) United States $2.802B 84.84
Nihon Kohden (NHNKY) Japan $2.648B 20.12
Elekta AB (EKTAY) Sweden $2.286B 18.62
Tandem Diabetes Care (TNDM) United States $2.010B 0.00
Integra LifeSciences Holdings (IART) United States $1.912B 9.99
RxSight (RXST) United States $1.776B 0.00
Alphatec Holdings (ATEC) United States $1.333B 0.00
Pulse Biosciences (PLSE) United States $1.222B 0.00
Artivion (AORT) United States $1.203B 79.75
OPKO Health (OPK) United States $1.060B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.938B 15.95
ORTHOFIX MEDICAL INC (OFIX) United States $0.741B 0.00
IRadimed (IRMD) United States $0.716B 38.68
Mesa Laboratories (MLAB) United States $0.643B 15.22
SiBone (SIBN) United States $0.639B 0.00
Pacific Biosciences Of California (PACB) United States $0.627B 0.00
OrthoPediatrics (KIDS) United States $0.623B 0.00
Paragon 28 (FNA) United States $0.597B 0.00
AxoGen (AXGN) United States $0.555B 0.00
Treace Medical Concepts (TMCI) United States $0.501B 0.00
CVRx (CVRX) United States $0.377B 0.00
Tactile Systems Technology (TCMD) United States $0.360B 19.51
ClearPoint Neuro (CLPT) United States $0.321B 0.00
Delcath Systems (DCTH) United States $0.307B 0.00
AngioDynamics (ANGO) United States $0.293B 0.00
Semler Scientific (SMLR) United States $0.289B 19.43
Inogen (INGN) United States $0.263B 0.00
NeuroPace (NPCE) United States $0.219B 0.00
Accuray (ARAY) United States $0.216B 0.00
Sight Sciences (SGHT) United States $0.213B 0.00
Nevro (NVRO) United States $0.189B 0.00
Atossa Genetics (ATOS) United States $0.189B 0.00
Alpha Tau Medical (DRTS) Israel $0.158B 0.00
KORU Medical Systems (KRMD) United States $0.132B 0.00
908 Devices (MASS) United States $0.124B 0.00
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.111B 16.51
EDAP TMS S.A (EDAP) France $0.095B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.082B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Covalon Technologies (CVALF) Canada $0.071B 0.00
Hyperfine (HYPR) United States $0.069B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
Lucid Diagnostics (LUCD) United States $0.056B 0.00
Rapid Micro Biosystems (RPID) United States $0.054B 0.00
Vicarious Surgical (RBOT) United States $0.050B 0.00
Accelerate Diagnostics (AXDX) United States $0.043B 0.00
Envoy Medical (COCH) United States $0.041B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Adagio Medical Holdings (ADGM) United States $0.034B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.025B 0.00
NexGel (NXGL) United States $0.020B 0.00
Baird Medical Investment Holdings (BDMD) $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.013B 0.00
PAVmed (PAVM) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.010B 0.00
Pixie Dust Technologies (PXDT) Japan $0.007B 0.00
Check-Cap (CHEK) Israel $0.006B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00